Investor Profile: Pillar VC — Thesis, Cheque Size & How to Apply

Pillar VC is a Boston seed-stage venture firm built by founders, for founders. Founded in 2016, it partners with technically brilliant founders at the inception stage, and Pillar VC funding is designed to be the first capital in, and it is unusual in a way that matters: its founding pillar chief executives are co-owners of the firm, so the people advising a portfolio company have often built category-defining companies themselves.

Investment thesis

The firm's thesis is that the biggest problems are solved by the best people, and that breakthrough research can become world-changing companies. It invests in engineers, researchers and scientists building solutions to the world's greatest challenges, and works with founders months to years in advance of commercialisation, collaborating with PhD students, postdocs and faculty. Its focus is strong founder-market fit, disruptive technology and defensible business models. A distinctive part of its alignment model is that it buys common stock, so it takes on the same risks as founders rather than sitting in a privileged share class.

Sectors and stages

Pillar VC invests at pre-seed, seed and Series A. Its sector scope is broad but technical: biology, enterprise software as a service, artificial intelligence and machine learning, crypto, fintech, hardware, manufacturing and logistics.

Fund size and cheque size

The firm is currently investing out of Pillar IV, a $175M fund. Its earlier funds set the scale of the platform: Pillar I raised $57 million, Pillar II raised $100 million, and Pillar III closed at $169 million alongside a $23 million Pillar Select fund, a combined $192 million raise. Reported cheque sizes range from $100K to $10M, while the Fund III era was described as pre-seed investments of $50,000 to $500,000 and seed investments of $2 million to $6 million.

Notable portfolio

Its portfolio reads like a Boston technology honour roll. It includes Circle, the cryptocurrency company; PillPack, the pharmacy company bought by Amazon in 2018; Abridge, healthcare communication; PathAI, AI-driven pathology; Asimov, synthetic biology; Neural Magic, machine learning optimisation; Algorand, blockchain; Desktop Metal, 3D printing, which went public; Jellyfish, engineering management; and Hometap, home equity.

Partners and programs

The investing team is led by founding and managing partner Jamie Goldstein, general partner Sarah Hodges, and partners Tony Kulesa and Parker McKee, alongside venture partners who are themselves founders and chief executives. Beyond capital, the firm offers coaching, peer groups for founders, and hands-on help validating customer demand, recruiting key team members, developing business plans, navigating licensing agreements and building syndicates with strong co-investors. It also runs Encode: AI for Science, a programme with its own executive director and head of operations.

How to apply for funding

There is no open application portal described on the firm's site. The route to how to get funding from Pillar VC is through its website at pillar.vc, whose published general contact is [email protected], or, far more powerfully, through a warm introduction from a founder, researcher, university contact or founding pillar in its network.